BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3078960)

  • 1. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The int-1 proto-oncogene is transcriptionally activated during neuroectodermal differentiation of P19 mouse embryonal carcinoma cells.
    St-Arnaud R; Craig J; McBurney MW; Papkoff J
    Oncogene; 1989 Sep; 4(9):1077-80. PubMed ID: 2674852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated expression of Wnt family members during neuroectodermal differentiation of P19 embryonal carcinoma cells: overexpression of Wnt-1 perturbs normal differentiation-specific properties.
    Smolich BD; Papkoff J
    Dev Biol; 1994 Nov; 166(1):300-10. PubMed ID: 7958454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Egr-1 (Zfp-6) and c-fos expression in differentiating embryonal carcinoma cells.
    Darland T; Samuels M; Edwards SA; Sukhatme VP; Adamson ED
    Oncogene; 1991 Aug; 6(8):1367-76. PubMed ID: 1909429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAZ, a Myc-associated zinc finger protein, is essential for the ME1a1-mediated expression of the c-myc gene during neuroectodermal differentiation of P19 cells.
    Komatsu M; Li HO; Tsutsui H; Itakura K; Matsumura M; Yokoyama KK
    Oncogene; 1997 Sep; 15(10):1123-31. PubMed ID: 9294605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous retinoic acid receptor beta 2 expression during mesoderm differentiation of P19 murine embryonal carcinoma cells.
    Pratt MA; Crippen CA; Ménard M
    Differentiation; 2000 May; 65(5):271-9. PubMed ID: 10929206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells.
    Slack RS; Hamel PA; Bladon TS; Gill RM; McBurney MW
    Oncogene; 1993 Jun; 8(6):1585-91. PubMed ID: 8502481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
    Boise LH; Gorse KM; Westin EH
    Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line.
    Miller WH; Moy D; Li A; Grippo JF; Dmitrovsky E
    Oncogene; 1990 Apr; 5(4):511-7. PubMed ID: 2158037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.
    Yang XM; Park M
    Dev Biol; 1993 Jun; 157(2):308-20. PubMed ID: 8388815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D; Tavassoli M; Linskens MH; Farzaneh F
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer.
    Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP
    Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
    Whitman MM; Shen YM; Soprano D; Soprano KJ
    Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation.
    Kazama H; Kodera T; Shimizu S; Mizoguchi H; Morishita K
    Cell Growth Differ; 1999 Aug; 10(8):565-73. PubMed ID: 10470856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc and c-fos gene regulation during mouse liver regeneration.
    Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
    Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.
    Thiele CJ
    Prog Clin Biol Res; 1991; 366():151-6. PubMed ID: 2068135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.